Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,400 | 179,300 | 271,513 | 308,304 | 280,499 |
| Receivables | 271,100 | 146,100 | 148,474 | 120,479 | 60,191 |
| Inventories | 205,800 | 142,800 | 74,002 | 60,887 | 65,674 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 1,710 |
| Other current assets | 0 | 0 | 0 | 29,282 | 0 |
| TOTAL | $620,800 | $485,400 | $510,218 | $537,410 | $432,175 |
| Non-Current Assets | |||||
| PPE Net | 510,200 | 407,200 | 376,448 | 327,808 | 313,979 |
| Intangibles | 1,021,300 | 168,700 | 74,866 | 81,759 | 110,929 |
| Other Non-Current Assets | 77,100 | 8,900 | 8,579 | 90,507 | 81,608 |
| TOTAL | $1,608,600 | $584,800 | $459,893 | $500,074 | $506,516 |
| Total Assets | $2,229,400 | $1,070,200 | $970,111 | $1,037,484 | $938,691 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,100 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 80,700 | 41,800 | 34,649 | 37,970 | 40,930 |
| Accrued Expenses | 88,900 | 42,700 | 40,905 | 38,205 | 37,928 |
| Other current liabilities | 20,700 | 2,400 | 3,266 | 2,109 | 8,733 |
| TOTAL | $200,400 | $100,100 | $105,856 | $99,611 | $92,936 |
| Non-Current Liabilities | |||||
| Long Term Debt | 784,500 | 13,500 | 248,094 | 246,892 | 251,000 |
| Deferred Revenues | N/A | 13,200 | 7,036 | 3,979 | 5,345 |
| Other Non-Current Liabilities | 103,600 | 27,000 | 11,523 | 27,538 | 35,841 |
| TOTAL | $1,018,100 | $57,800 | $268,050 | $277,856 | $292,554 |
| Total Liabilities | $1,218,500 | $157,900 | $373,906 | $377,467 | $385,490 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,200 | 49,495 | 40,688 | 39,474 | 37,918 |
| Common Shares | 100 | 100 | 41 | 40 | 38 |
| Retained earnings | 367,300 | 337,100 | 254,480 | 351,139 | 288,269 |
| Other shareholders' equity | -5,100 | -3,200 | -4,751 | -3,133 | -3,328 |
| TOTAL | $1,010,900 | $912,300 | $596,205 | $660,017 | $553,201 |
| Total Liabilities And Equity | $2,229,400 | $1,070,200 | $970,111 | $1,037,484 | $938,691 |